Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma...
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy
About this item
Full title
Author / Creator
Costantini, Susan , Madonna, Gabriele , Capone, Mariaelena , Di Gennaro, Elena , Bagnara, Palmina , Renza, Federica , Mallardo, Domenico , Affatato, Roberta , Vitagliano, Carlo , Romanelli, Marilena , Tuffanelli, Marilena , Simeone, Ester , Ciliberto, Gennaro , Ascierto, Paolo A. and Budillon, Alfredo
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Immune checkpoint inhibitors (ICIs), such as anti-Cytotoxic T-Lymphocyte Antigen 4(CTLA-4) and anti-Programmed cell death protein 1 (PD-1) agents, have improved the prognosis of patients with metastatic melanoma. However, a proportion of patients develop resistance to these treatments, leading to a poor prognosis. Therefore, identifying potential n...
Alternative Titles
Full title
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c67f28f7116246c7a668d652ad0d9b5f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c67f28f7116246c7a668d652ad0d9b5f
Other Identifiers
ISSN
1756-9966,0392-9078
E-ISSN
1756-9966
DOI
10.1186/s13046-025-03378-8
